Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cyclophosphamide/methylprednisolone/prednisone

Cyclophosphamide/methylprednisolone/prednisone Reactions 1680, p103 - 2 Dec 2017 Cyclophosphamide/ methylprednisolone/prednisone Various toxicities: case report A 75-year-old woman developed herpes zoster, influenza A infection, bacteraemia secondary to the Rothia species following treatment with methylprednisolone, cyclophosphamide and prednisone. The woman, who was diagnosed with IgA nephropathy with superimposed pauci-immune anti-neutrophilic cytoplasmic antibody (ANCA)- associated crescentic glomerulonephritis, received three doses of IV methylprednisolone 1000 mg/day, followed by oral prednisone 60 mg/day, in the hospital. Following a renal biopsy after the initial treatment, IV cyclophosphamide 700mg was administered on day 12 of hospitalisation. Later, she was discharged. One month thereafter, she received her second dose of cyclophosphamide. Eight days later, she was admitted to the ICU for generalised malaise and fever with a right-sided vesicular rash in a dermatomal distribution on the trunk, suggesting herpes zoster. The woman was treated with acyclovir. Subsequently, she developed influenza A infection, bacteraemia secondary to the Rothia species and diarrhoea [not all durations of treatments to reactions onset stated]. Thus, she received treatment with metronidazole, vancomycin and oseltamivir. Consequently, she recovered from all the infections. Author comment: "Unfortunately, most immunosuppressive regimens carry life-threatening risks including infection-related complications, especially in the elderly population." Nissaisorakarn P, et al. ANCA and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Cyclophosphamide/methylprednisolone/prednisone

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Download PDF
1 page

Cyclophosphamide/methylprednisolone/prednisone

Abstract

Reactions 1680, p103 - 2 Dec 2017 Cyclophosphamide/ methylprednisolone/prednisone Various toxicities: case report A 75-year-old woman developed herpes zoster, influenza A infection, bacteraemia secondary to the Rothia species following treatment with methylprednisolone, cyclophosphamide and prednisone. The woman, who was diagnosed with IgA nephropathy with superimposed pauci-immune anti-neutrophilic cytoplasmic antibody (ANCA)- associated crescentic glomerulonephritis, received three doses of...
Loading next page...
1
 
/lp/springer_journal/cyclophosphamide-methylprednisolone-prednisone-jsMtWaLWxt

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-017-39034-8
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p103 - 2 Dec 2017 Cyclophosphamide/ methylprednisolone/prednisone Various toxicities: case report A 75-year-old woman developed herpes zoster, influenza A infection, bacteraemia secondary to the Rothia species following treatment with methylprednisolone, cyclophosphamide and prednisone. The woman, who was diagnosed with IgA nephropathy with superimposed pauci-immune anti-neutrophilic cytoplasmic antibody (ANCA)- associated crescentic glomerulonephritis, received three doses of IV methylprednisolone 1000 mg/day, followed by oral prednisone 60 mg/day, in the hospital. Following a renal biopsy after the initial treatment, IV cyclophosphamide 700mg was administered on day 12 of hospitalisation. Later, she was discharged. One month thereafter, she received her second dose of cyclophosphamide. Eight days later, she was admitted to the ICU for generalised malaise and fever with a right-sided vesicular rash in a dermatomal distribution on the trunk, suggesting herpes zoster. The woman was treated with acyclovir. Subsequently, she developed influenza A infection, bacteraemia secondary to the Rothia species and diarrhoea [not all durations of treatments to reactions onset stated]. Thus, she received treatment with metronidazole, vancomycin and oseltamivir. Consequently, she recovered from all the infections. Author comment: "Unfortunately, most immunosuppressive regimens carry life-threatening risks including infection-related complications, especially in the elderly population." Nissaisorakarn P, et al. ANCA and

Journal

Reactions Weekly – Springer Journals

Published: Dec 2, 2017

There are no references for this article.